Advertisement

Topics

Sage surges 54% on postpartum depression data

11:50 EST 10 Nov 2017 | thePharmaLetter

Sage Therapeutics scored a massive win for its investors and potentially for patients too as its Phase…

Original Article: Sage surges 54% on postpartum depression data

NEXT ARTICLE

More From BioPortfolio on "Sage surges 54% on postpartum depression data"

Advertisement
Quick Search
Advertisement
Advertisement